Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8608960rdf:typepubmed:Citationlld:pubmed
pubmed-article:8608960lifeskim:mentionsumls-concept:C0086427lld:lifeskim
pubmed-article:8608960lifeskim:mentionsumls-concept:C0024204lld:lifeskim
pubmed-article:8608960lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:8608960lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:8608960lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:8608960lifeskim:mentionsumls-concept:C0032520lld:lifeskim
pubmed-article:8608960lifeskim:mentionsumls-concept:C0406582lld:lifeskim
pubmed-article:8608960lifeskim:mentionsumls-concept:C0035380lld:lifeskim
pubmed-article:8608960lifeskim:mentionsumls-concept:C0599161lld:lifeskim
pubmed-article:8608960lifeskim:mentionsumls-concept:C0162788lld:lifeskim
pubmed-article:8608960pubmed:issue1lld:pubmed
pubmed-article:8608960pubmed:dateCreated1996-5-29lld:pubmed
pubmed-article:8608960pubmed:abstractTextTo examine the relationship between human T-lymphotrophic virus type I (HTLV-I) proviral DNA and its expression in the lymph nodes, HTLV-I DNA and tax/rex mRDA were directly amplified by polymerase chain reaction in situ hybridization (PCR/ISH), and reverse transcription (RT)-PCR/ISH [RT-PCR/ISH]. We studied 24 lymph nodes from patients with adult T-cell leukemia/lymphoma (ATLL), incipient ATLL (I-ATLL), and HTLV-I associated lymphadenitis dermatopathic type (HAL-D) and enlarged paracortical type (HAL-EP). In ATLL, 40-60% of the nucleated cells were positive for for HTLV-I proviral DNA by PCR/ISH, while in I-ATLL and HAL, respectively 5-20% and less than 1-5% of cells were positive. The number of mRNA expressing cells was smaller than that of the proviral DNA-positive cells. The mRNA-expressing cells varied in number among the ATLL and I-ATLL cases, while they were only rarely observed in HAL-D and HAL-EP. These results show that HTLV-I infection and activation might increase with malignant transformation of the target T helper cells.lld:pubmed
pubmed-article:8608960pubmed:languageenglld:pubmed
pubmed-article:8608960pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8608960pubmed:citationSubsetIMlld:pubmed
pubmed-article:8608960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8608960pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8608960pubmed:statusMEDLINElld:pubmed
pubmed-article:8608960pubmed:monthMarlld:pubmed
pubmed-article:8608960pubmed:issn0020-7136lld:pubmed
pubmed-article:8608960pubmed:authorpubmed-author:KikuchiMMlld:pubmed
pubmed-article:8608960pubmed:authorpubmed-author:TashiroKKlld:pubmed
pubmed-article:8608960pubmed:authorpubmed-author:OhshimaKKlld:pubmed
pubmed-article:8608960pubmed:authorpubmed-author:IzumoSSlld:pubmed
pubmed-article:8608960pubmed:authorpubmed-author:SuzumiyaJJlld:pubmed
pubmed-article:8608960pubmed:authorpubmed-author:MukaiYYlld:pubmed
pubmed-article:8608960pubmed:issnTypePrintlld:pubmed
pubmed-article:8608960pubmed:day28lld:pubmed
pubmed-article:8608960pubmed:volume66lld:pubmed
pubmed-article:8608960pubmed:ownerNLMlld:pubmed
pubmed-article:8608960pubmed:authorsCompleteYlld:pubmed
pubmed-article:8608960pubmed:pagination18-23lld:pubmed
pubmed-article:8608960pubmed:dateRevised2007-7-24lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:meshHeadingpubmed-meshheading:8608960-...lld:pubmed
pubmed-article:8608960pubmed:year1996lld:pubmed
pubmed-article:8608960pubmed:articleTitleDetection of human T-lymphotropic virus type-I DNA and mRNA in the lymph nodes; using polymerase chain reaction in situ hybridization (PCR/ISH) and reverse transcription (RT-PCR/ISH).lld:pubmed
pubmed-article:8608960pubmed:affiliationDepartment of Pathology, School of Medicine, Fukuoka University, Japan.lld:pubmed
pubmed-article:8608960pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8608960lld:pubmed